View ValuationDo-Fluoride New Materials 향후 성장Future 기준 점검 4/6Do-Fluoride New Materials (는) 각각 연간 22.6% 및 21.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 22.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 10.9% 로 예상됩니다.핵심 정보22.6%이익 성장률22.87%EPS 성장률Chemicals 이익 성장30.5%매출 성장률21.6%향후 자기자본이익률10.86%애널리스트 커버리지Low마지막 업데이트26 Apr 2026최근 향후 성장 업데이트Major Estimate Revision • Apr 30Consensus EPS estimates increase by 24%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from CN¥0.744 to CN¥0.921. Revenue forecast steady at CN¥15.8b. Net income forecast to grow 112% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥45.00 to CN¥39.00. Share price rose 21% to CN¥36.31 over the past week.Major Estimate Revision • Dec 04Consensus EPS estimates fall by 20%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.125 to CN¥0.10 per share. Revenue forecast steady at CN¥10.4b. Net income forecast to grow 221% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥15.00 unchanged from last update. Share price fell 2.7% to CN¥13.16 over the past week.Price Target Changed • Nov 16Price target decreased to CN¥25.00Down from CN¥27.00, the current price target is provided by 1 analyst. New target price is 27% below last closing price of CN¥34.32. Stock is down 35% over the past year. The company is forecast to post earnings per share of CN¥2.44 for next year compared to CN¥1.73 last year.Major Estimate Revision • Jul 14Consensus EPS estimates increase by 37%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥13.8b to CN¥14.1b. EPS estimate increased from CN¥2.04 to CN¥2.79 per share. Net income forecast to grow 24% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥27.00 unchanged from last update. Share price fell 15% to CN¥46.83 over the past week.Major Estimate Revision • Jun 01Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥14.8b to CN¥13.8b. EPS estimate also fell from CN¥2.82 per share to CN¥2.04 per share. Net income forecast to shrink 6.7% next year vs 40% growth forecast for Chemicals industry in China . Consensus price target down from CN¥42.00 to CN¥27.00. Share price fell 2.1% to CN¥38.69 over the past week.Price Target Changed • Apr 27Price target decreased to CN¥52.63Down from CN¥59.13, the current price target is provided by 1 analyst. New target price is 69% above last closing price of CN¥31.09. Stock is up 31% over the past year. The company is forecast to post earnings per share of CN¥2.82 for next year compared to CN¥1.73 last year.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • May 29Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to CN¥33.70, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 72% over the past three years.New Risk • May 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change).Major Estimate Revision • Apr 30Consensus EPS estimates increase by 24%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from CN¥0.744 to CN¥0.921. Revenue forecast steady at CN¥15.8b. Net income forecast to grow 112% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥45.00 to CN¥39.00. Share price rose 21% to CN¥36.31 over the past week.Reported Earnings • Apr 16Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: CN¥0.18 (up from CN¥0.26 loss in FY 2024). Revenue: CN¥9.43b (up 15% from FY 2024). Net income: CN¥212.8m (up CN¥521.3m from FY 2024). Profit margin: 2.3% (up from net loss in FY 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) exceeded analyst estimates by 52%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.New Risk • Apr 16New major risk - Revenue and earnings growthEarnings have declined by 33% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 33% per year over the past 5 years.공시 • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026New Risk • Mar 08New major risk - Revenue and earnings growthEarnings have declined by 22% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 22% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change).공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026New Risk • Nov 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows.Reported Earnings • Oct 23Third quarter 2025 earnings released: EPS: CN¥0.023 (vs CN¥0.039 loss in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.023 (up from CN¥0.039 loss in 3Q 2024). Revenue: CN¥2.40b (up 5.2% from 3Q 2024). Net income: CN¥26.7m (up CN¥72.9m from 3Q 2024). Profit margin: 1.1% (up from net loss in 3Q 2024). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.New Risk • Oct 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025Reported Earnings • Aug 27Second quarter 2025 earnings released: CN¥0.011 loss per share (vs CN¥0.017 profit in 2Q 2024)Second quarter 2025 results: CN¥0.011 loss per share (down from CN¥0.017 profit in 2Q 2024). Revenue: CN¥2.23b (down 11% from 2Q 2024). Net loss: CN¥13.4m (down 158% from profit in 2Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.공시 • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025Board Change • Apr 26Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Deputy GM, Financial Director, CFO & Non Independent Director Li Jing Cheng was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 25Do-Fluoride New Materials Co., Ltd. Proposes Final Cash Distribution for 2024Do-Fluoride New Materials Co., Ltd. announced on 24 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.Reported Earnings • Apr 24First quarter 2025 earnings released: EPS: CN¥0.06 (vs CN¥0.04 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.06 (up from CN¥0.04 in 1Q 2024). Revenue: CN¥2.10b (down 1.5% from 1Q 2024). Net income: CN¥64.7m (up 64% from 1Q 2024). Profit margin: 3.1% (up from 1.9% in 1Q 2024). Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.공시 • Apr 24Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025공시 • Jan 23Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million.Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million on January 21, 2025. A cash consideration of CNY 28.46 million will be paid by Do-Fluoride New Materials Co., Ltd. As part of consideration, CNY 28.46 million is paid towards common equity of Henan Yifeng Electronic New Materials Co., Ltd. The transaction will be financed through equity investment of CNY 28.46 million. As of October 31, 2024 Henan Yifeng Electronic New Materials Co., Ltd. reported total assets of CNY 65 million and net assets of CNY 40 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board.공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025Major Estimate Revision • Dec 04Consensus EPS estimates fall by 20%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.125 to CN¥0.10 per share. Revenue forecast steady at CN¥10.4b. Net income forecast to grow 221% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥15.00 unchanged from last update. Share price fell 2.7% to CN¥13.16 over the past week.Reported Earnings • Nov 01Third quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.14 profit in 3Q 2023)Third quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥2.27b (down 36% from 3Q 2023). Net loss: CN¥45.4m (down 123% from profit in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.42, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.58 per share.공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥11.38, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.26 per share.Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.022 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥2.48b (down 11% from 2Q 2023). Net income: CN¥30.8m (down 81% from 2Q 2023). Profit margin: 1.2% (down from 5.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has fallen by 34% per year, which means it is performing significantly worse than earnings.공시 • Jun 29Do-Fluoride New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥2.13b (down 14% from 1Q 2023). Net income: CN¥39.6m (down 64% from 1Q 2023). Profit margin: 1.9% (down from 4.4% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 7% per year.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥13.39, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 7.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.88 per share.공시 • Mar 30Do-Fluoride New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024공시 • Mar 29Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan ChinaReported Earnings • Mar 29Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥509.8m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 4.5%. Earnings per share (EPS) also missed analyst estimates by 23%. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥508.6m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥10.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years.공시 • Dec 30Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.31 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥3.52b (up 7.7% from 3Q 2022). Net income: CN¥194.4m (down 41% from 3Q 2022). Profit margin: 5.5% (down from 10.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.63 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.63 in 2Q 2022). Revenue: CN¥2.79b (down 17% from 2Q 2022). Net income: CN¥158.5m (down 76% from 2Q 2022). Profit margin: 5.7% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 23Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: CN¥2.54 (up from CN¥1.73 in FY 2021). Revenue: CN¥12.4b (up 58% from FY 2021). Net income: CN¥1.95b (up 55% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Independent Director Chunyan Li was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥38.26, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 230% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share.Price Target Changed • Nov 16Price target decreased to CN¥25.00Down from CN¥27.00, the current price target is provided by 1 analyst. New target price is 27% below last closing price of CN¥34.32. Stock is down 35% over the past year. The company is forecast to post earnings per share of CN¥2.44 for next year compared to CN¥1.73 last year.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.57 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.43 (down from CN¥0.57 in 3Q 2021). Revenue: CN¥3.27b (up 36% from 3Q 2021). Net income: CN¥326.6m (down 24% from 3Q 2021). Profit margin: 10.0% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.88 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥3.37b (up 102% from 2Q 2021). Net income: CN¥670.6m (up 212% from 2Q 2021). Profit margin: 20% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 33%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Jul 14Consensus EPS estimates increase by 37%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥13.8b to CN¥14.1b. EPS estimate increased from CN¥2.04 to CN¥2.79 per share. Net income forecast to grow 24% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥27.00 unchanged from last update. Share price fell 15% to CN¥46.83 over the past week.Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥47.51, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 270% over the past three years.Major Estimate Revision • Jun 01Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥14.8b to CN¥13.8b. EPS estimate also fell from CN¥2.82 per share to CN¥2.04 per share. Net income forecast to shrink 6.7% next year vs 40% growth forecast for Chemicals industry in China . Consensus price target down from CN¥42.00 to CN¥27.00. Share price fell 2.1% to CN¥38.69 over the past week.Valuation Update With 7 Day Price Move • May 20Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥39.15, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 242% over the past three years.Buying Opportunity • Apr 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥38.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 108%. Revenue is forecast to grow by 63% in 2 years. Earnings is forecast to grow by 3.5% in the next 2 years.Price Target Changed • Apr 27Price target decreased to CN¥52.63Down from CN¥59.13, the current price target is provided by 1 analyst. New target price is 69% above last closing price of CN¥31.09. Stock is up 31% over the past year. The company is forecast to post earnings per share of CN¥2.82 for next year compared to CN¥1.73 last year.Price Target Changed • Apr 20Price target decreased to CN¥52.63Down from CN¥61.63, the current price target is an average from 2 analysts. New target price is 51% above last closing price of CN¥34.85. Stock is up 66% over the past year. The company is forecast to post earnings per share of CN¥2.73 for next year compared to CN¥1.73 last year.공시 • Apr 13Do-Fluoride New Materials Co., Ltd. Approves Cash Dividend for 2021Do-Fluoride New Materials Co., Ltd., at the AGM held on 11 April 2022 approved Cash dividend/10 shares (tax included) of CNY 3.00000000 for 2021.Major Estimate Revision • Mar 23Consensus revenue estimates increase by 53%The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from CN¥10.4b to CN¥15.9b. EPS estimate increased from CN¥2.50 to CN¥2.76 per share. Net income forecast to grow 98% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥61.63 to CN¥59.13. Share price was steady at CN¥42.88 over the past week.Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: CN¥1.73 (up from CN¥0.07 in FY 2020). Revenue: CN¥7.81b (up 84% from FY 2020). Net income: CN¥1.26b (up CN¥1.21b from FY 2020). Profit margin: 16% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥36.38, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 126% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.72 per share.공시 • Nov 25Do-Fluoride New Materials Co., Ltd. announced that it expects to receive CNY 5.5 billion in fundingDo-Fluoride New Materials Co., Ltd. announced that it will receive CNY 5.5 billion in equity funding on November 24, 2021.Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥60.22, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 537% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥48.57 per share.Reported Earnings • Oct 16Third quarter 2021 earnings released: EPS CN¥0.57 (vs CN¥0.003 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.40b (up 111% from 3Q 2020). Net income: CN¥429.4m (up CN¥431.5m from 3Q 2020). Profit margin: 18% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.021 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.67b (up 81% from 2Q 2020). Net income: CN¥214.7m (up CN¥200.2m from 2Q 2020). Profit margin: 13% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings.Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.071 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 117 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 09Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Jan 18New 90-day high: CN¥21.23The company is up 33% from its price of CN¥15.94 on 20 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 24New 90-day high: CN¥18.74The company is up 54% from its price of CN¥12.14 on 24 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.Is New 90 Day High Low • Dec 08New 90-day high: CN¥17.26The company is up 52% from its price of CN¥11.32 on 09 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.Is New 90 Day High Low • Nov 05New 90-day high: CN¥16.32The company is up 43% from its price of CN¥11.39 on 07 August 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.84 per share.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥504.7m, with losses widening by CN¥499.6m from the prior year. Total revenue was CN¥3.74b over the last 12 months, down 13% from the prior year.공시 • Oct 19Do-Fluoride Chemicals Co., Ltd. to Report Q3, 2020 Results on Oct 26, 2020Do-Fluoride Chemicals Co., Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020Is New 90 Day High Low • Oct 09New 90-day high: CN¥13.80The company is up 16% from its price of CN¥11.92 on 10 July 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.40 per share.공시 • Oct 02Xingtai Longgang Investment Co., Ltd agreed to acquire remaining 89.85% in Hebei Red Star Automobile Manufacturing Co., Ltd. from Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) and New Energy Development and Investment Center (Limited Partnership) for approximately CNY 209.5 million.Xingtai Longgang Investment Co., Ltd agreed to acquire remaining 89.85% in Hebei Red Star Automobile Manufacturing Co., Ltd. from Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) and New Energy Development and Investment Center (Limited Partnership) for approximately CNY 209.5 million on October 1, 2020. In the disposal, Do-Fluoride Chemicals Co., Ltd. will dispose of 58.88% stake for CNY 137.3 million and New Energy Development and Investment Center (Limited Partnership) will dispose of 30.97% for CNY 72.23 million to Xingtai Longgang Investment Co., Ltd. As of July 31, 2020, Hebei Red Star Automobile Manufacturing Co., Ltd. recorded total assets of CNY 427 million, total common equity of CNY 111.6 million and total revenue of CNY 1.85 million. The transaction is approved by board of directors of Do-Fluoride Chemicals Co., Ltd. and needs to be approved by shareholders of Do-Fluoride Chemicals Co., Ltd.Is New 90 Day High Low • Sep 18New 90-day high: CN¥13.32The company is up 21% from its price of CN¥11.00 on 19 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.34 per share.공시 • Sep 04Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) completed the acquisition of 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd.Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) intent to acquire 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. for CNY 27.5 million on August 25, 2020. Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) completed the acquisition of 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. on September 1, 2020.공시 • Aug 26Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) intent to acquire 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. for CNY 27.5 million.Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) intent to acquire 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. for CNY 27.5 million on August 25, 2020.공시 • Aug 12Do-Fluoride Chemicals Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020Do-Fluoride Chemicals Co., Ltd. announced that they will report first half, 2020 results on Aug 28, 2020공시 • Jul 17Do-Fluoride Chemicals Co., Ltd. announced that it expects to receive CNY 1.15 billion in fundingDo-Fluoride Chemicals Co., Ltd. (SZSE:002407) announced a private placement of not more than 205,176,144 A shares at CNY 5.60494 per share for gross proceeds of not more that CNY 1,150,000,000 on July 10, 2020. The transaction will include participation from 35 investors. The transaction has been reviewed and approved in the eighth meeting of the sixth session of the board of directors. The transaction is still needs an approval from the shareholders of the company and by the the China Securities Regulatory Commission. The transaction is subject to a lock-up period of six months.이익 및 매출 성장 예측SZSE:002407 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202820,5921,234N/AN/A112/31/202719,6951,151N/AN/A112/31/202615,7731,096N/AN/A13/31/202610,552524-1,162-278N/A12/31/20259,434213-858199N/A9/30/20258,017-246-468679N/A6/30/20257,899-319-689573N/A3/31/20258,204-282-1,022129N/A12/31/20248,249-308-1,334-313N/A9/30/202410,07164-1,834-881N/A6/30/202411,309304-2,446-1,604N/A3/31/202411,609440-1,461-252N/A12/31/202311,938511-1,183330N/A9/30/202311,848681-7081,152N/A6/30/202311,596814-422,128N/A3/31/202312,1761,326-1,1351,219N/A1/1/202312,3581,948-8211,753N/A9/30/202211,7882,252-2772,213N/A6/30/202210,9212,3552282,506N/A3/31/20229,2161,8995852,354N/A12/31/20217,8091,2607581,975N/A9/30/20216,671772-6892N/A6/30/20215,409341-624-9N/A3/31/20214,661141-43340N/A12/31/20204,24549-440-37N/A9/30/20203,829-49970270N/A6/30/20203,717-483212455N/A3/31/20203,919-454-135147N/A12/31/20193,998-411N/A45N/A9/30/20194,3110N/A73N/A6/30/20194,26423N/A321N/A3/31/20193,99334N/A431N/A12/31/20183,94566N/A428N/A9/30/20183,962217N/A153N/A6/30/20183,940237N/A-181N/A3/31/20183,952264N/A10N/A12/31/20173,768257N/A28N/A9/30/20173,250307N/A44N/A6/30/20173,133378N/A248N/A3/31/20173,007435N/A128N/A12/31/20162,871478N/A61N/A9/30/20162,843389N/A30N/A6/30/20162,484280N/A-75N/A3/31/20162,276143N/A-115N/A12/31/20152,19739N/A78N/A9/30/20152,12137N/A-115N/A6/30/20152,24524N/A11N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002407 의 연간 예상 수익 증가율(22.6%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002407 의 연간 수익(22.6%)이 CN 시장(27%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 002407 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 002407 의 수익(연간 21.6%)이 CN 시장(연간 16.3%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 002407 의 수익(연간 21.6%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002407의 자본 수익률은 3년 후 10.9%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/31 07:35종가2026/05/29 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Do-Fluoride New Materials Co., Ltd.는 4명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Zhe WangCitic Securities Co., Ltd.Dongying WuCitigroup IncJack LuMorgan Stanley1명의 분석가 더 보기
Major Estimate Revision • Apr 30Consensus EPS estimates increase by 24%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from CN¥0.744 to CN¥0.921. Revenue forecast steady at CN¥15.8b. Net income forecast to grow 112% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥45.00 to CN¥39.00. Share price rose 21% to CN¥36.31 over the past week.
Major Estimate Revision • Dec 04Consensus EPS estimates fall by 20%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.125 to CN¥0.10 per share. Revenue forecast steady at CN¥10.4b. Net income forecast to grow 221% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥15.00 unchanged from last update. Share price fell 2.7% to CN¥13.16 over the past week.
Price Target Changed • Nov 16Price target decreased to CN¥25.00Down from CN¥27.00, the current price target is provided by 1 analyst. New target price is 27% below last closing price of CN¥34.32. Stock is down 35% over the past year. The company is forecast to post earnings per share of CN¥2.44 for next year compared to CN¥1.73 last year.
Major Estimate Revision • Jul 14Consensus EPS estimates increase by 37%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥13.8b to CN¥14.1b. EPS estimate increased from CN¥2.04 to CN¥2.79 per share. Net income forecast to grow 24% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥27.00 unchanged from last update. Share price fell 15% to CN¥46.83 over the past week.
Major Estimate Revision • Jun 01Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥14.8b to CN¥13.8b. EPS estimate also fell from CN¥2.82 per share to CN¥2.04 per share. Net income forecast to shrink 6.7% next year vs 40% growth forecast for Chemicals industry in China . Consensus price target down from CN¥42.00 to CN¥27.00. Share price fell 2.1% to CN¥38.69 over the past week.
Price Target Changed • Apr 27Price target decreased to CN¥52.63Down from CN¥59.13, the current price target is provided by 1 analyst. New target price is 69% above last closing price of CN¥31.09. Stock is up 31% over the past year. The company is forecast to post earnings per share of CN¥2.82 for next year compared to CN¥1.73 last year.
Valuation Update With 7 Day Price Move • May 29Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to CN¥33.70, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 72% over the past three years.
New Risk • May 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change).
Major Estimate Revision • Apr 30Consensus EPS estimates increase by 24%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from CN¥0.744 to CN¥0.921. Revenue forecast steady at CN¥15.8b. Net income forecast to grow 112% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥45.00 to CN¥39.00. Share price rose 21% to CN¥36.31 over the past week.
Reported Earnings • Apr 16Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: CN¥0.18 (up from CN¥0.26 loss in FY 2024). Revenue: CN¥9.43b (up 15% from FY 2024). Net income: CN¥212.8m (up CN¥521.3m from FY 2024). Profit margin: 2.3% (up from net loss in FY 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) exceeded analyst estimates by 52%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.
New Risk • Apr 16New major risk - Revenue and earnings growthEarnings have declined by 33% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 33% per year over the past 5 years.
공시 • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
New Risk • Mar 08New major risk - Revenue and earnings growthEarnings have declined by 22% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 22% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change).
공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026
New Risk • Nov 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows.
Reported Earnings • Oct 23Third quarter 2025 earnings released: EPS: CN¥0.023 (vs CN¥0.039 loss in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.023 (up from CN¥0.039 loss in 3Q 2024). Revenue: CN¥2.40b (up 5.2% from 3Q 2024). Net income: CN¥26.7m (up CN¥72.9m from 3Q 2024). Profit margin: 1.1% (up from net loss in 3Q 2024). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.
New Risk • Oct 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025
Reported Earnings • Aug 27Second quarter 2025 earnings released: CN¥0.011 loss per share (vs CN¥0.017 profit in 2Q 2024)Second quarter 2025 results: CN¥0.011 loss per share (down from CN¥0.017 profit in 2Q 2024). Revenue: CN¥2.23b (down 11% from 2Q 2024). Net loss: CN¥13.4m (down 158% from profit in 2Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
공시 • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
Board Change • Apr 26Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Deputy GM, Financial Director, CFO & Non Independent Director Li Jing Cheng was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 25Do-Fluoride New Materials Co., Ltd. Proposes Final Cash Distribution for 2024Do-Fluoride New Materials Co., Ltd. announced on 24 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.
Reported Earnings • Apr 24First quarter 2025 earnings released: EPS: CN¥0.06 (vs CN¥0.04 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.06 (up from CN¥0.04 in 1Q 2024). Revenue: CN¥2.10b (down 1.5% from 1Q 2024). Net income: CN¥64.7m (up 64% from 1Q 2024). Profit margin: 3.1% (up from 1.9% in 1Q 2024). Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
공시 • Apr 24Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
공시 • Jan 23Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million.Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million on January 21, 2025. A cash consideration of CNY 28.46 million will be paid by Do-Fluoride New Materials Co., Ltd. As part of consideration, CNY 28.46 million is paid towards common equity of Henan Yifeng Electronic New Materials Co., Ltd. The transaction will be financed through equity investment of CNY 28.46 million. As of October 31, 2024 Henan Yifeng Electronic New Materials Co., Ltd. reported total assets of CNY 65 million and net assets of CNY 40 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board.
공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025
Major Estimate Revision • Dec 04Consensus EPS estimates fall by 20%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.125 to CN¥0.10 per share. Revenue forecast steady at CN¥10.4b. Net income forecast to grow 221% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥15.00 unchanged from last update. Share price fell 2.7% to CN¥13.16 over the past week.
Reported Earnings • Nov 01Third quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.14 profit in 3Q 2023)Third quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥2.27b (down 36% from 3Q 2023). Net loss: CN¥45.4m (down 123% from profit in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.42, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.58 per share.
공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥11.38, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.26 per share.
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.022 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥2.48b (down 11% from 2Q 2023). Net income: CN¥30.8m (down 81% from 2Q 2023). Profit margin: 1.2% (down from 5.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has fallen by 34% per year, which means it is performing significantly worse than earnings.
공시 • Jun 29Do-Fluoride New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥2.13b (down 14% from 1Q 2023). Net income: CN¥39.6m (down 64% from 1Q 2023). Profit margin: 1.9% (down from 4.4% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 7% per year.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥13.39, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 7.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.88 per share.
공시 • Mar 30Do-Fluoride New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
공시 • Mar 29Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
Reported Earnings • Mar 29Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥509.8m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 4.5%. Earnings per share (EPS) also missed analyst estimates by 23%. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥508.6m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥10.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years.
공시 • Dec 30Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.31 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥3.52b (up 7.7% from 3Q 2022). Net income: CN¥194.4m (down 41% from 3Q 2022). Profit margin: 5.5% (down from 10.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.63 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.63 in 2Q 2022). Revenue: CN¥2.79b (down 17% from 2Q 2022). Net income: CN¥158.5m (down 76% from 2Q 2022). Profit margin: 5.7% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 23Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: CN¥2.54 (up from CN¥1.73 in FY 2021). Revenue: CN¥12.4b (up 58% from FY 2021). Net income: CN¥1.95b (up 55% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Independent Director Chunyan Li was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥38.26, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 230% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share.
Price Target Changed • Nov 16Price target decreased to CN¥25.00Down from CN¥27.00, the current price target is provided by 1 analyst. New target price is 27% below last closing price of CN¥34.32. Stock is down 35% over the past year. The company is forecast to post earnings per share of CN¥2.44 for next year compared to CN¥1.73 last year.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.57 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.43 (down from CN¥0.57 in 3Q 2021). Revenue: CN¥3.27b (up 36% from 3Q 2021). Net income: CN¥326.6m (down 24% from 3Q 2021). Profit margin: 10.0% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.88 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥3.37b (up 102% from 2Q 2021). Net income: CN¥670.6m (up 212% from 2Q 2021). Profit margin: 20% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 33%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Jul 14Consensus EPS estimates increase by 37%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥13.8b to CN¥14.1b. EPS estimate increased from CN¥2.04 to CN¥2.79 per share. Net income forecast to grow 24% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥27.00 unchanged from last update. Share price fell 15% to CN¥46.83 over the past week.
Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥47.51, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 270% over the past three years.
Major Estimate Revision • Jun 01Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥14.8b to CN¥13.8b. EPS estimate also fell from CN¥2.82 per share to CN¥2.04 per share. Net income forecast to shrink 6.7% next year vs 40% growth forecast for Chemicals industry in China . Consensus price target down from CN¥42.00 to CN¥27.00. Share price fell 2.1% to CN¥38.69 over the past week.
Valuation Update With 7 Day Price Move • May 20Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥39.15, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 242% over the past three years.
Buying Opportunity • Apr 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥38.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 108%. Revenue is forecast to grow by 63% in 2 years. Earnings is forecast to grow by 3.5% in the next 2 years.
Price Target Changed • Apr 27Price target decreased to CN¥52.63Down from CN¥59.13, the current price target is provided by 1 analyst. New target price is 69% above last closing price of CN¥31.09. Stock is up 31% over the past year. The company is forecast to post earnings per share of CN¥2.82 for next year compared to CN¥1.73 last year.
Price Target Changed • Apr 20Price target decreased to CN¥52.63Down from CN¥61.63, the current price target is an average from 2 analysts. New target price is 51% above last closing price of CN¥34.85. Stock is up 66% over the past year. The company is forecast to post earnings per share of CN¥2.73 for next year compared to CN¥1.73 last year.
공시 • Apr 13Do-Fluoride New Materials Co., Ltd. Approves Cash Dividend for 2021Do-Fluoride New Materials Co., Ltd., at the AGM held on 11 April 2022 approved Cash dividend/10 shares (tax included) of CNY 3.00000000 for 2021.
Major Estimate Revision • Mar 23Consensus revenue estimates increase by 53%The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from CN¥10.4b to CN¥15.9b. EPS estimate increased from CN¥2.50 to CN¥2.76 per share. Net income forecast to grow 98% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥61.63 to CN¥59.13. Share price was steady at CN¥42.88 over the past week.
Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: CN¥1.73 (up from CN¥0.07 in FY 2020). Revenue: CN¥7.81b (up 84% from FY 2020). Net income: CN¥1.26b (up CN¥1.21b from FY 2020). Profit margin: 16% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥36.38, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 126% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.72 per share.
공시 • Nov 25Do-Fluoride New Materials Co., Ltd. announced that it expects to receive CNY 5.5 billion in fundingDo-Fluoride New Materials Co., Ltd. announced that it will receive CNY 5.5 billion in equity funding on November 24, 2021.
Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥60.22, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 537% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥48.57 per share.
Reported Earnings • Oct 16Third quarter 2021 earnings released: EPS CN¥0.57 (vs CN¥0.003 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.40b (up 111% from 3Q 2020). Net income: CN¥429.4m (up CN¥431.5m from 3Q 2020). Profit margin: 18% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.021 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.67b (up 81% from 2Q 2020). Net income: CN¥214.7m (up CN¥200.2m from 2Q 2020). Profit margin: 13% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.071 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 117 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 09Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Jan 18New 90-day high: CN¥21.23The company is up 33% from its price of CN¥15.94 on 20 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 24New 90-day high: CN¥18.74The company is up 54% from its price of CN¥12.14 on 24 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Dec 08New 90-day high: CN¥17.26The company is up 52% from its price of CN¥11.32 on 09 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Nov 05New 90-day high: CN¥16.32The company is up 43% from its price of CN¥11.39 on 07 August 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.84 per share.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥504.7m, with losses widening by CN¥499.6m from the prior year. Total revenue was CN¥3.74b over the last 12 months, down 13% from the prior year.
공시 • Oct 19Do-Fluoride Chemicals Co., Ltd. to Report Q3, 2020 Results on Oct 26, 2020Do-Fluoride Chemicals Co., Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020
Is New 90 Day High Low • Oct 09New 90-day high: CN¥13.80The company is up 16% from its price of CN¥11.92 on 10 July 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.40 per share.
공시 • Oct 02Xingtai Longgang Investment Co., Ltd agreed to acquire remaining 89.85% in Hebei Red Star Automobile Manufacturing Co., Ltd. from Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) and New Energy Development and Investment Center (Limited Partnership) for approximately CNY 209.5 million.Xingtai Longgang Investment Co., Ltd agreed to acquire remaining 89.85% in Hebei Red Star Automobile Manufacturing Co., Ltd. from Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) and New Energy Development and Investment Center (Limited Partnership) for approximately CNY 209.5 million on October 1, 2020. In the disposal, Do-Fluoride Chemicals Co., Ltd. will dispose of 58.88% stake for CNY 137.3 million and New Energy Development and Investment Center (Limited Partnership) will dispose of 30.97% for CNY 72.23 million to Xingtai Longgang Investment Co., Ltd. As of July 31, 2020, Hebei Red Star Automobile Manufacturing Co., Ltd. recorded total assets of CNY 427 million, total common equity of CNY 111.6 million and total revenue of CNY 1.85 million. The transaction is approved by board of directors of Do-Fluoride Chemicals Co., Ltd. and needs to be approved by shareholders of Do-Fluoride Chemicals Co., Ltd.
Is New 90 Day High Low • Sep 18New 90-day high: CN¥13.32The company is up 21% from its price of CN¥11.00 on 19 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.34 per share.
공시 • Sep 04Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) completed the acquisition of 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd.Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) intent to acquire 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. for CNY 27.5 million on August 25, 2020. Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) completed the acquisition of 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. on September 1, 2020.
공시 • Aug 26Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) intent to acquire 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. for CNY 27.5 million.Do-Fluoride Chemicals Co., Ltd. (SZSE:002407) intent to acquire 51% stake in Henan Zhongse Oriental Shaoxing Industrial Co., Ltd. from Henan Fuxing Enterprise Service Co., Ltd. for CNY 27.5 million on August 25, 2020.
공시 • Aug 12Do-Fluoride Chemicals Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020Do-Fluoride Chemicals Co., Ltd. announced that they will report first half, 2020 results on Aug 28, 2020
공시 • Jul 17Do-Fluoride Chemicals Co., Ltd. announced that it expects to receive CNY 1.15 billion in fundingDo-Fluoride Chemicals Co., Ltd. (SZSE:002407) announced a private placement of not more than 205,176,144 A shares at CNY 5.60494 per share for gross proceeds of not more that CNY 1,150,000,000 on July 10, 2020. The transaction will include participation from 35 investors. The transaction has been reviewed and approved in the eighth meeting of the sixth session of the board of directors. The transaction is still needs an approval from the shareholders of the company and by the the China Securities Regulatory Commission. The transaction is subject to a lock-up period of six months.